Citius Pharmaceuticals Inc [NASDAQ: CTXR] price surged by 5092442 percent to reach at $2169998.97.
A sum of 5092442 shares traded at recent session while its average daily volume was at 2.17M shares. Citius Pharmaceuticals Inc shares reached a high of $1.33 and dropped to a low of $0.995 until finishing in the latest session at $2170000.0.
The one-year CTXR stock forecast points to a potential downside of -43399900.0. The average equity rating for CTXR stock is currently 1.67, trading closer to a bullish pattern in the stock market.
Guru’s Opinion on Citius Pharmaceuticals Inc [CTXR]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for CTXR shares is $5.00 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on CTXR stock is a recommendation set at 1.67. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
D. Boral Capital have made an estimate for Citius Pharmaceuticals Inc shares, keeping their opinion on the stock as Buy, with their previous recommendation back on December 30, 2024. While these analysts kept the previous recommendation, Maxim Group raised their target price to Buy. The new note on the price target was released on November 30, 2021, representing the official price target for Citius Pharmaceuticals Inc stock.
The Price to Book ratio for the last quarter was 0.19, with the Price to Cash per share for the same quarter was set at 0.00.
CTXR Stock Performance Analysis:
Citius Pharmaceuticals Inc [CTXR] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 63.27. With this latest performance, CTXR shares gained by 78.18% in over the last four-week period, additionally sinking by -50.19% over the last 6 months – not to mention a drop of -67.75% in the past year of trading.
Insight into Citius Pharmaceuticals Inc Fundamentals:
Return on Equity for this stock declined to -39.63%, with Return on Assets sitting at -39.63%.
Citius Pharmaceuticals Inc [CTXR] Institutonal Ownership Details
There are presently around $5.74%, or 6.01% of CTXR stock, in the hands of institutional investors. The top three institutional holders of CTXR stocks are: ARMISTICE CAPITAL, LLC with ownership of 10.16 million shares, which is approximately 6.3845%. VANGUARD GROUP INC, holding 6.33 million shares of the stock with an approximate value of $$3.69 million in CTXR stocks shares; and VANGUARD GROUP INC, currently with $$1.2 million in CTXR stock with ownership which is approximately 1.288%.
